» Articles » PMID: 37878959

Single-Exon Deletions of ZNRF3 Exon 2 Cause Congenital Adrenal Hypoplasia

Overview
Specialty Endocrinology
Date 2023 Oct 25
PMID 37878959
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Primary adrenal insufficiency (PAI) is a life-threatening condition characterized by the inability of the adrenal cortex to produce sufficient steroid hormones. E3 ubiquitin protein ligase zinc and ring finger 3 (ZNRF3) is a negative regulator of Wnt/β-catenin signaling. R-spondin 1 (RSPO1) enhances Wnt/β-catenin signaling via binding and removal of ZNRF3 from the cell surface.

Objective: This work aimed to explore a novel genetic form of PAI.

Methods: We analyzed 9 patients with childhood-onset PAI of biochemically and genetically unknown etiology using array comparative genomic hybridization. To examine the functionality of the identified single-exon deletions of ZNRF3 exon 2, we performed three-dimensional (3D) structure modeling and in vitro functional studies.

Results: We identified various-sized single-exon deletions encompassing ZNRF3 exon 2 in 3 patients who showed neonatal-onset adrenal hypoplasia with glucocorticoid and mineralocorticoid deficiencies. Reverse-transcriptase polymerase chain reaction (RT-PCR) analysis showed that the 3 distinct single-exon deletions were commonly transcribed into a 126-nucleotide deleted mRNA and translated into 42-amino acid deleted protein (ΔEx2-ZNRF3). Based on 3D structure modeling, we predicted that interaction between ZNRF3 and RSPO1 would be disturbed in ΔEx2-ZNRF3, suggesting loss of RSPO1-dependent activation of Wnt/β-catenin signaling. Cell-based functional assays with the TCF-LEF reporter showed that RSPO1-dependent activation of Wnt/β-catenin signaling was attenuated in cells expressing ΔEx2-ZNRF3 as compared with those expressing wild-type ZNRF3.

Conclusion: We provided genetic evidence linking deletions encompassing ZNRF3 exon 2 and congenital adrenal hypoplasia, which might be related to constitutive inactivation of Wnt/β-catenin signaling by ΔEx2-ZNRF3.

Citing Articles

Lack of dominant-negative activity for tumor-related ZNRF3 missense mutations at endogenous levels.

Li S, Niu J, Zhang R, Massaar S, Neves Cabrita M, van Merode J Oncogene. 2024; .

PMID: 39674817 DOI: 10.1038/s41388-024-03253-4.


Deleterious ZNRF3 germline variants cause neurodevelopmental disorders with mirror brain phenotypes via domain-specific effects on Wnt/β-catenin signaling.

Boonsawat P, Asadollahi R, Niedrist D, Steindl K, Begemann A, Joset P Am J Hum Genet. 2024; 111(9):1994-2011.

PMID: 39168120 PMC: 11393693. DOI: 10.1016/j.ajhg.2024.07.016.


Letter to the Editor From Janot et al: « Single-Exon Deletions of ZNRF3 Exon 2 Cause Congenital Adrenal Hypoplasia ».

Janot C, Bachelot A, Mallet D, Simon D, Val P, Roucher-Boulez F J Clin Endocrinol Metab. 2024; 109(9):e1808-e1809.

PMID: 38589987 PMC: 11318992. DOI: 10.1210/clinem/dgae229.